Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Carditis

fluorodeoxyglucose f18 has been researched along with Carditis in 108 studies

Research

Studies (108)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (2.78)29.6817
2010's38 (35.19)24.3611
2020's67 (62.04)2.80

Authors

AuthorsStudies
Aaronson, K; Cascino, T; Koelling, T; Kopin, D; Murthy, VL; Patel, VN; Pieper, JA; Poitrasson-Rivière, A1
Balakrishnan, ID; Chan, LL; Khoo, CY; Ng, CT; Prameswari, HS; Teo, LY1
Blankstein, R; Castor, T; Dittmann, H; Gatidis, S; Gawaz, M; Glatthaar, A; Gräni, C; Greulich, S; Häntschel, M; Hetzel, J; Krumm, P; la Fougère, C; Mahrholdt, H; Mezger, K; Müller, KAL; Nikolaou, K1
Miller, EJ; Park, J; Young, BD1
Fujii, S; Fukuda, M; Ishiguchi, H; Kawano, R; Kobayashi, S; Nakashima, Y; Nanno, T; Okamura, T; Suga, K; Yano, M; Yano, Y; Yoshiga, Y; Yoshitomi, R1
Abbar, B; Allenbach, Y; Bretagne, M; Cohen, AA; Devos, P; Ederhy, S; Fenioux, C; Funck-Brentano, E; Kharroubi, D; Moslehi, J; Pinna, B; Salem, JE1
Kong, EJ; Lee, CH1
Lu, Y1
Bois, JP; Chareonthaitawee, P; Elwazir, MY1
Aitken, M; Balter, M; Chan, MV; Farrell, A; Hanneman, K; Islam, N; Iwanochko, M; McInnes, MDF; Metser, U; Moayedi, Y; Thavendiranathan, P; Urzua Fresno, C; Veit-Haibach, P1
Andrade, LGF; Brandão, SCS; Galvão, MFR; Gouveia, PADC; Lins, EM; Moraes Neto, F; Perazzo, AM; Venancio, LGA1
Ieda, M; Ishizu, T; Kawamatsu, N; Machino-Ohtsuka, T; Sato, K; Yamamoto, M1
Eugene, T; Fellah, I; Guyomarch, B; Jamet, B; Marteau, L; Piriou, N; Probst, V; Sébille, JC; Serfaty, JM; Tessier, R; Thollet, A; Toquet, C; Trochu, JN; Vivien, M; Warin-Fresse, K1
Higashi, H; Inoue, T; Kawaguchi, N; Kido, T; Matsuoka, M; Miyagawa, M; Miyoshi, T; Okada, T; Okayama, H; Tanabe, Y; Tashiro, R; Yamaguchi, O1
Aguilar-Gallardo, JS; Arreaza, J; Contreras, JP; Lasam, G; Omar, A1
Dong, J; Du, X; Li, Q; Li, S; Liu, T; Lv, Q; Ma, C; Wang, H; Xiong, R; Yang, X1
Greulich, S; Krumm, P; la Fougère, C; Nikolaou, K1
Kupari, M; Lehtonen, J; Niemelä, M; Pöyhönen, P; Schildt, J; Uusitalo, V1
Kaneko, K; Nagao, M; Sakai, A; Sakai, S; Yamamoto, A1
Amara, RS; Dickfeld, T1
Basso, C; Busnardo, E; Campochiaro, C; Dagna, L; De Gaspari, M; De Luca, G; Della Bella, P; Esposito, A; Ferro, P; Gianolli, L; Palmisano, A; Peretto, G; Rizzo, S; Sala, S; Sartorelli, S; Vignale, D1
Campisi, R; Merani, MF; Rodríguez, MI1
Lan, X; Qin, C; Song, W; Zhang, X1
Adams, SL; Bhattaru, A; Bravo, PE; Clancy, CB; Dubroff, J; Goldberg, L; Jean, C; Marchlinski, FE; Patel, V; Patterson, K; Peyster, E; Rojulpote, C; Rossman, M; Selvaraj, S; Vidula, MK1
Blankstein, R; Divakaran, S1
Adhaduk, M; Ashwath, M; Khalid, MU; Liu, K; Mansour, S; Paudel, B1
Abe, T; Bekki, M; Fukumoto, Y; Fukuoka, R; Honda, A; Igata, S; Maeda-Ogata, S; Sugiyama, Y; Tahara, A; Tahara, N1
Alpendurada, F; Azzu, A; Baksi, J; Gardezi, SKM; Hatipoglu, S; Izgi, C; Khattar, R; Kouranos, V; Mohiaddin, R; Pennell, DJ; Sharma, R; Wechalekar, K; Wells, AU1
Park, JB; Sohn, DW1
Akdim, F; Grutters, JC; Keijsers, RGM; Mathijssen, H; Post, MC; van de Garde, EMW; Veltkamp, M; Vis, R1
Arment, CA; Bois, JP; Chareonthaitawee, P; Cooper, LT; Elwazir, MY; Ezzeddine, OFA; Kolluri, N; Rosenbaum, AN; Sykora, D; Young, KA1
Aitken, M; Balter, M; Broncano, J; Chan, MV; Davidson, M; Farrell, A; Hanneman, K; Huo, YR; Iwanochko, MR; McAllister, BJ; McInnes, MDF; Moayedi, Y; Thavendiranathan, P; Urzua Fresno, C; Vasquez, LI1
Barkmeier, D; Davenport, MS; Frey, KA; Saleh, JK1
Fujiki, S; Inomata, T; Ishihara, S; Ishizuka, M; Kase, M; Kashimura, T; Okubo, T; Ozaki, K; Sakai, R; Takayama, T; Watanabe, M1
Alshaheen, M; Beanlands, R; Birnie, D; Boczar, KE; Caires, MC; Chow, BJ; deKemp, R; Lauzier, PT; Wiefels, C1
Griffin, JM1
Iso-Mustajärvi, S; Sillanmäki, S1
Cadrin-Tourigny, J; Harel, F; Lucinian, YA; Martineau, P; Pelletier-Galarneau, M; Poenaru, R; Tremblay-Gravel, M1
Chen, X; Sun, J; Wang, F; Wang, Y; Zhou, W1
Abou Ezzeddine, OF; Ackerman, MJ; Bois, JP; Cooper, LT; Fink, AL; Garmany, R; Giudicessi, JR; Homb, AC; MacIntyre, CJ; McLeod, CJ; Neves, R; Pereira, NL; Rosenbaum, AN; Siontis, KC; Tseng, AS1
Divakaran, S; John, LA; Tedrow, UB1
Birnie, DH; Culver, DA; De Bortoli, A; Kron, J; Lehtonen, J; Murgatroyd, F; Nagai, T; Nery, PB1
Bhambhvani, P; Farag, AA; Hage, FG; Kherajani, P; Morgan, WS1
Arment, C; Bois, J; Castrichini, M; Churchill, R; Elwazir, M; Myasoedova, E; Rosenbaum, A; Sykora, D; Young, K1
Fujii, S; Ishiguchi, H; Kajii, T; Kobayashi, S; Kohno, M; Nanno, T; Okada, M; Okuda, S; Suga, K; Yano, M; Yoshitomi, R1
Dharmakumar, R; Goldhawk, DE; Prato, FS; Thiessen, JD; Wilk, B; Wisenberg, G1
Atkins, D; Bommana, S; Carroll, H; Dar, T; Di Biase, L; Gopinathannair, R; Hamblin, M; Krause, M; Lakkireddy, D; Mohanty, S; Natale, A; Nydegger, C; Parikh, V; Rosamond, T; Turagam, MK; Wetzel, L; Yarlagadda, B1
Almufleh, A; Beanlands, RSB; Birnie, D; Chih, S; Lamacie, MM; Nair, V; Stadnick, E1
Bokhari, S; Fazlollahi, L; Nickerson, K; Perel-Winkler, A; Simon, R1
Basso, C; Busnardo, E; Calcagno, C; Campochiaro, C; De Cobelli, F; De Luca, G; Del Maschio, A; Esposito, A; Ferro, P; Palmisano, A; Peretto, G; Sala, S; Vignale, D1
Emdin, M; Genovesi, D; Giorgetti, A1
Chong, A; Cole, C; Cooper, C; Kaye, G; Law, P; Reyaldeen, R; Wahi, S1
Berman, DS; Cadet, S; Friedman, J; Hamilton, MA; Hayes, S; Kransdorf, E; Miller, RJH; Patel, J; Pope, A; Pournazari, P; Slomka, PJ; Tamarappoo, B; Thomson, L1
Birnie, DH1
Hanaoka, K; Ishii, K; Iwanaga, Y; Kagioka, Y; Kaida, H; Kakehi, K; Kawamura, T; Miyazaki, S; Nakazawa, G; Okune, M; Soejima, N; Yasuda, M1
Noll, AE; Varma, N; William, AD1
Ali, AZ; Kishore, J; Narasimhan, C; Saggu, DK; Subramanian, M; Swamy, LTN; Swapna, N; Yalagudri, S1
Caforio, ALP; Grabowski, M; Kobylecka, M; Królicki, L; Maksimović, R; Marcolongo, R; Opolski, G; Ozierański, K; Ristić, AD; Seferović, PM; Šobić-Šaranović, D; Tymińska, A1
Avery, R; Cao, J; Cooper, LT; Lomasney, JW; Narang, A; Okwuosa, IS; Passman, RS; Schwartz, YY; Vorovich, E1
Cadrin-Tourigny, J; Giraldeau, G; Gregoire, J; Jordà, P; Robillard, J1
Agrawal, T; Al-Mallah, M; Alnabelsi, TS; Bhimaraj, A; Kassi, M; Khan, M; Saleh, Y; Sukkari, MH1
Abe, T; Bekki, M; Enomoto, M; Fukumoto, Y; Honda, A; Igata, S; Kaida, H; Kakuma, T; Maeda-Ogata, S; Sugiyama, Y; Tahara, A; Tahara, N1
Andrikopoulou, E; Bajaj, N; Bhambhvani, P; Manapragada, PP1
Guo, HH; Hanneman, K; Herfkens, R; Iagaru, A; Jamali, M; Kadoch, M; Quon, A1
Nishiyama, Y; Noma, T; Norikane, T; Yamamoto, Y1
Danwade, TA; Devidutta, S; Narasimhan, C; Reddy, NK; Saggu, DK; Shelke, AB; Sridevi, C; Yalagudri, SD1
Thackeray, JT1
Bauer, J; Ergün, S; Hayakawa, N; Higuchi, T; Jahns, R; Jahns, V; Javadi, MS; Lapa, C; Schütz, C; Wakabayashi, H; Werner, RA; Zechmeister, C1
Boutley, H; Clément, A; Karcher, G; Kolodziej, A; Lhuillier, M; Marie, PY; Maskali, F; Olivier, JL; Pierson, J; Poussier, S1
Bengel, FM; Thackeray, JT1
Wechalekar, K1
Amigues, I; Bathon, JM; Bokhari, S; Flores, R; Giles, JT; Morgenstein, R; Russo, C; Schulze, C; Tugcu, A; Zartoshti, A1
Ashworth, M; Elliott, P; Guttmann, O; Menezes, L; Mohiddin, SA; Protonotarios, A; Savvatis, K; Sekhri, N; Stephenson, E; Syrris, P; Wicks, E1
Better, N; Montalto, S1
Kim, K; Kim, SJ; Pak, K1
Rischpler, C; Woodard, PK1
Alavi, A; Castro, SA; Muser, D; Santangeli, P1
Bajaj, N; Bibbo, CF; Blankstein, R; Bravo, PE; Di Carli, MF; Dorbala, S; Groarke, J; Hainer, J; Harrington, M; Hyun, H; Lakdawala, NK; Morgan, V; Padera, RF; Park, MA; Robertson, M; Stewart, GC1
Chen, W; Jeudy, J1
Narula, J; Narula, N; Zubin Maslov, P1
Fukushima, Y; Ishihara, K; Kobayashi, Y; Kumita, S; Sakurai, M; Suda, M1
Daimon, M; Funabashi, N; Kobayashi, Y; Ozawa, K; Takano, H; Takaoka, H; Uehara, M1
Krings, P; Nensa, F; Poeppel, TD; Schlosser, T1
Hyafil, F; Ibrahim, T; Langwieser, N; Laugwitz, KL; Schwaiger, M; von Olshausen, G1
Pallardy, A; Piriou, N; Sassier, J; Serfaty, JM; Trochu, JN1
Karunanithi, S; Malhotra, A; Nadig, M; Nagesh, CM; Patel, C; Saxena, A1
Hsich, EM; Oldan, JD; Reynolds, JP; Sperry, BW; Tamarappoo, BK1
Bauer, WR; Buck, AK; Ertl, G; Jahns, R; Lapa, C; Li, X; Reiter, T; Samnick, S; Werner, RA1
Ajijola, O; Auerbach, M; Barrio, M; Bauer, B; Bradfield, J; Chan, S; Ferris, J; Gupta, P; Lynch, JP; Schelbert, H; Schiepers, C; Shivkumar, K; Tung, R1
Al-Faham, Z; Alchammas, J; Roumayah, Y; Wong, OC1
Bokhari, S; Chen, J; DeLuca, A; Morgenstern, R; Weinberg, RL1
Blankstein, R; DiCarli, MF; Dorbala, S; Hulten, EA; Murthy, VL; Osborne, MT; Skali, H; Taqueti, VR1
Abgral, R; Contreras, J; Dweck, MR; Fayad, ZA; Fuster, V; Karakatsanis, N; Kovacic, JC; Lala, A; Mani, V; Miller, M; Narula, J; Padilla, M; Robson, PM; Sanz, J; Trivieri, MG1
Goebel, J; Heusch, P; Kloth, J; Nassenstein, K; Nensa, F; Poeppel, TD; Schlosser, T; Tezgah, E1
Langwieser, N; Nekolla, SG; Rischpler, C1
Aleksova, N; Beanlands, RS; Birnie, D; Dick, A; Green, M; Juneau, D; Nery, PB1
Chen, ES; Kasper, EK; Kovell, L; Kruse, MJ; Moller, DR; Pomper, MG; Schindler, TH; Solnes, L1
Begieneman, MP; Di Carli, M; Dutta, P; Gorbatov, R; Iwamoto, Y; Lee, WW; Leuschner, F; Marinelli, B; Nahrendorf, M; Niessen, HW; Piek, JJ; Pittet, MJ; Sena, BF; Swirski, FK; Tawakol, A; Ueno, T; van der Laan, AM; Vinegoni, C; Weissleder, R1
Blier, L; Champagne, J; Charbonneau, L; Guimond, J; Molin, F; Nadeau, M; Nault, I; O'Hara, G; Philippon, F; Sarrazin, JF; Tessier, M; Trottier, M1
Brinker, J1
Cohen, P; Duboc, D; Guillevin, L; Guilpain, P; Legmann, P; Marmursztejn, J; Mouthon, L; Pagnoux, C; Trebossen, R; Vignaux, O1
Sharma, A1
Bandera, F; Erba, PA; Sollini, M; Tascini, C1
Beck, H; Dickfeld, T; Dilsizian, V1
Brillet, PY; Naggara, N; Nunes, H; Ouvrier, MJ; Pop, G; Soussan, M; Valeyre, D; Weinmann, P1
Bleeker-Rovers, CP; Oyen, WJ; van Dijk, AP; Vos, FJ1
Dumarey, N; Goldman, S; Matos, C; Nortier, J; Tang, BN; Unger, P; Wautrecht, JC1
Amaravadi, RR; Behr, SC; Kousoubris, PD; Raja, S1

Reviews

19 review(s) available for fluorodeoxyglucose f18 and Carditis

ArticleYear
Potential novel imaging targets of inflammation in cardiac sarcoidosis.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2022, Volume: 29, Issue:5

    Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Inflammation; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sarcoidosis

2022
Utilization of cardiac imaging in sarcoidosis.
    Expert review of cardiovascular therapy, 2022, Volume: 20, Issue:4

    Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Myocarditis; Positron-Emission Tomography; Sarcoidosis

2022
Diagnostic Accuracy of Cardiac MRI versus FDG PET for Cardiac Sarcoidosis: A Systematic Review and Meta-Analysis.
    Radiology, 2022, Volume: 304, Issue:3

    Topics: Adult; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Sensitivity and Specificity

2022
[Hybrid PET/MRI for inflammatory cardiomyopathy].
    Radiologie (Heidelberg, Germany), 2022, Volume: 62, Issue:11

    Topics: Fluorodeoxyglucose F18; Humans; Inflammation; Magnetic Resonance Imaging; Myocarditis; Positron-Emission Tomography; Sarcoidosis

2022
Assessment of Cardiac Sarcoidosis: FDG PET and BMIPP SPECT.
    Current cardiology reports, 2022, Volume: 24, Issue:12

    Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Inflammation; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tomography, Emission-Computed, Single-Photon

2022
Comparison of cardiac magnetic resonance imaging and fluorodeoxyglucose positron emission tomography in the assessment of cardiac sarcoidosis: Meta-analysis and systematic review.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2023, Volume: 30, Issue:4

    Topics: Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Sensitivity and Specificity

2023
Cardiac sarcoidosis.
    Heart (British Cardiac Society), 2023, 07-12, Volume: 109, Issue:15

    Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Heart; Humans; Myocarditis; Positron-Emission Tomography; Sarcoidosis

2023
Prognostic Value of Cardiac MRI and FDG PET in Cardiac Sarcoidosis: A Systematic Review and Meta-Analysis.
    Radiology, 2023, Volume: 307, Issue:2

    Topics: Adult; Cardiomyopathies; Contrast Media; Fluorodeoxyglucose F18; Gadolinium; Humans; Magnetic Resonance Imaging; Myocarditis; Prognosis; Sarcoidosis

2023
Hybrid PET/MR imaging in myocardial inflammation post-myocardial infarction.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2020, Volume: 27, Issue:6

    Topics: Animals; Blood Flow Velocity; Disease Models, Animal; Dogs; Edema; Fluorodeoxyglucose F18; Heart; Humans; Inflammation; Machine Learning; Macrophages; Magnetic Resonance Imaging; Multimodal Imaging; Myocardial Infarction; Myocarditis; Positron-Emission Tomography

2020
Myocarditis in Giant Cell Arteritis Diagnosed With Fluorine 18-Labeled Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography: Case Report and Review of the Literature.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2020, Volume: 26, Issue:2

    Topics: Aged; Diagnosis, Differential; Dose-Response Relationship, Drug; Echocardiography; Fluorodeoxyglucose F18; Giant Cell Arteritis; Glucocorticoids; Humans; Male; Myocarditis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Stroke Volume; Treatment Outcome

2020
The Role of 18FDG PET/CT in the Assessment of Endocarditis, Myocarditis and Pericarditis.
    Current radiopharmaceuticals, 2021, Volume: 14, Issue:3

    Topics: Cardiomyopathies; Endocarditis; Fluorodeoxyglucose F18; Heart Valve Prosthesis; Humans; Myocarditis; Pericarditis; Positron Emission Tomography Computed Tomography; Prosthesis-Related Infections; Radiopharmaceuticals; Sarcoidosis

2021
Diagnosis of cardiac sarcoidosis: a primer for non-imagers.
    Heart failure reviews, 2022, Volume: 27, Issue:4

    Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Inflammation; Myocarditis; Positron-Emission Tomography; Sarcoidosis

2022
PET Cardiac Imaging (Perfusion, Viability, Sarcoidosis, and Infection).
    Radiologic clinics of North America, 2021, Volume: 59, Issue:5

    Topics: Cardiomyopathies; Cardiovascular Diseases; Fluorodeoxyglucose F18; Humans; Myocardial Perfusion Imaging; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis

2021
PET Assessment of Immune Cell Activity and Therapeutic Monitoring Following Myocardial Infarction.
    Current cardiology reports, 2018, 03-06, Volume: 20, Issue:3

    Topics: Fluorodeoxyglucose F18; Humans; Macrophages; Magnetic Resonance Imaging; Monocytes; Myocardial Infarction; Myocarditis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Ventricular Remodeling

2018
Molecular Imaging of Myocardial Inflammation With Positron Emission Tomography Post-Ischemia: A Determinant of Subsequent Remodeling or Recovery.
    JACC. Cardiovascular imaging, 2018, Volume: 11, Issue:9

    Topics: Animals; Fluorodeoxyglucose F18; Humans; Inflammation Mediators; Molecular Imaging; Myocardial Ischemia; Myocarditis; Myocardium; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Recovery of Function; Ventricular Remodeling

2018
Diagnostic performance of F-18 FDG PET for detection of cardiac sarcoidosis; A systematic review and meta-analysis.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2020, Volume: 27, Issue:6

    Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; ROC Curve; Sarcoidosis; Sensitivity and Specificity

2020
PET/MR Imaging in Cardiovascular Imaging.
    PET clinics, 2019, Volume: 14, Issue:2

    Topics: Cardiomyopathies; Cardiovascular Diseases; Contrast Media; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Angiography; Multimodal Imaging; Myocardial Perfusion Imaging; Myocarditis; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon

2019
Potential Role of PET in Assessing Ventricular Arrhythmias.
    PET clinics, 2019, Volume: 14, Issue:2

    Topics: Arrhythmias, Cardiac; Cardiomyopathies; Chagas Cardiomyopathy; Fluorodeoxyglucose F18; Humans; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Sarcoidosis

2019
Assessment of Myocarditis: Cardiac MR, PET/CT, or PET/MR?
    Current cardiology reports, 2019, 06-26, Volume: 21, Issue:8

    Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies

2019

Other Studies

89 other study(ies) available for fluorodeoxyglucose f18 and Carditis

ArticleYear
The prognostic value of positron emission tomography in the evaluation of suspected cardiac sarcoidosis.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2022, Volume: 29, Issue:5

    Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Myocarditis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Stroke Volume; Ventricular Function, Left

2022
The role of multimodality imaging in diagnosing acute perimyocarditis secondary to Crohn's disease.
    BMC cardiovascular disorders, 2021, 09-10, Volume: 21, Issue:1

    Topics: Acute Disease; Adult; Crohn Disease; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Myocarditis; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Symptom Flare Up; Treatment Outcome

2021
Hybrid Cardiac Magnetic Resonance/Fluorodeoxyglucose Positron Emission Tomography to Differentiate Active From Chronic Cardiac Sarcoidosis.
    JACC. Cardiovascular imaging, 2022, Volume: 15, Issue:3

    Topics: Cardiomyopathies; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Myocarditis; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed

2022
Enhanced oxidative stress and presence of ventricular aneurysm for risk prediction in cardiac sarcoidosis.
    Heart (British Cardiac Society), 2022, Volume: 108, Issue:6

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Biomarkers; Cardiomyopathies; Death, Sudden, Cardiac; Fluorodeoxyglucose F18; Heart Aneurysm; Humans; Myocarditis; Oxidative Stress; Prospective Studies; Risk Factors; Sarcoidosis; Tachycardia, Ventricular

2022
    Archives of cardiovascular diseases, 2022, Volume: 115, Issue:2

    Topics: Fluorodeoxyglucose F18; Humans; Immune Checkpoint Inhibitors; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals

2022
FDG PET/MRI of Acute Myocarditis After mRNA COVID-19 Vaccination.
    Clinical nuclear medicine, 2022, May-01, Volume: 47, Issue:5

    Topics: Adult; Contrast Media; COVID-19; COVID-19 Vaccines; Fluorodeoxyglucose F18; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Myocarditis; RNA, Messenger; Vaccination; Young Adult

2022
Extensive Biventricular Cardiac Sarcoidosis Detected on FDG PET/CT Using a 72-Hour Ketogenic Diet Preparation Protocol.
    Clinical nuclear medicine, 2022, Aug-01, Volume: 47, Issue:8

    Topics: Cardiomyopathies; Contrast Media; Diet, Ketogenic; Fluorodeoxyglucose F18; Gadolinium; Humans; Male; Middle Aged; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sarcoidosis

2022
Value of18F-FDG PET/CT in the Diagnosis and Assessment of Response to Treatment of Lupus Myocarditis.
    Arquivos brasileiros de cardiologia, 2022, Volume: 118, Issue:6

    Topics: Fluorodeoxyglucose F18; Humans; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals

2022
Utility of Updated Japanese Circulation Society Guidelines to Diagnose Isolated Cardiac Sarcoidosis.
    Journal of the American Heart Association, 2022, 07-05, Volume: 11, Issue:13

    Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Japan; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Stroke Volume; Ventricular Function, Left

2022
18F-Fluorodeoxyglucose Positron Emission Tomography for the Detection of Myocardial Inflammation in Arrhythmogenic Left Ventricular Cardiomyopathy.
    Circulation. Cardiovascular imaging, 2022, Volume: 15, Issue:7

    Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Inflammation; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals

2022
Clinical features and prognosis of isolated cardiac sarcoidosis diagnosed using new guidelines with dedicated FDG PET/CT.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2023, Volume: 30, Issue:1

    Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis

2023
Successful treatment of cardiac sarcoidosis based on clinical suspicion and advanced cardiac imaging: A case report.
    Medicine, 2022, Aug-26, Volume: 101, Issue:34

    Topics: Aged; Cardiomyopathies; Fluorodeoxyglucose F18; Heart Failure; Humans; Male; Myocarditis; Sarcoidosis; Stroke Volume; Ventricular Function, Left

2022
Adalimumab for the treatment of cardiac sarcoidosis with multiple arrhythmias.
    ESC heart failure, 2022, Volume: 9, Issue:6

    Topics: Adalimumab; Arrhythmias, Cardiac; Atrioventricular Block; Cardiomyopathies; Contrast Media; Fluorodeoxyglucose F18; Gadolinium; Humans; Inflammation; Male; Middle Aged; Mycophenolic Acid; Myocarditis; Positron Emission Tomography Computed Tomography; Sarcoidosis

2022
Incidence and Predictors of Atrial Fibrillation in Cardiac Sarcoidosis: A Multimodality Imaging Study.
    JACC. Cardiovascular imaging, 2022, Volume: 15, Issue:9

    Topics: Atrial Fibrillation; Female; Fluorodeoxyglucose F18; Heart Atria; Humans; Incidence; Inflammation; Middle Aged; Myocarditis; Predictive Value of Tests; Sarcoidosis; Tomography, X-Ray Computed

2022
FDG uptake patterns in isolated and systemic cardiac sarcoidosis.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2023, Volume: 30, Issue:3

    Topics: Cardiomyopathies; Energy Metabolism; Fluorodeoxyglucose F18; Humans; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis

2023
Acute Myocarditis: No Longer a PET Peeve?
    JACC. Cardiovascular imaging, 2022, Volume: 15, Issue:10

    Topics: Fluorodeoxyglucose F18; Humans; Myocarditis; Positron-Emission Tomography; Predictive Value of Tests

2022
Clinical Applications of FDG-PET Scan in Arrhythmic Myocarditis.
    JACC. Cardiovascular imaging, 2022, Volume: 15, Issue:10

    Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocarditis; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sarcoidosis

2022
Different displays of
    European journal of nuclear medicine and molecular imaging, 2023, Volume: 50, Issue:3

    Topics: Fluorodeoxyglucose F18; Gallium Radioisotopes; Heart Failure; Humans; Immune Checkpoint Inhibitors; Myocarditis; Perfusion; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Quinolines

2023
Effect of Immunosuppressive Therapy and Biopsy Status in Monitoring Therapy Response in Suspected Cardiac Sarcoidosis.
    JACC. Cardiovascular imaging, 2022, Volume: 15, Issue:11

    Topics: Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Immunosuppression Therapy; Male; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Predictive Value of Tests; Prednisone; Radiopharmaceuticals; Sarcoidosis

2022
Treating Myocardial Inflammation in Cardiac Sarcoidosis: Why, With What, and for How Long?
    JACC. Cardiovascular imaging, 2022, Volume: 15, Issue:11

    Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Inflammation; Myocarditis; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sarcoidosis

2022
Utility of very long fasting to detect myocardial inflammation in cardiac sarcoidosis.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2023, Volume: 30, Issue:5

    Topics: Cardiomyopathies; Fasting; Fluorodeoxyglucose F18; Humans; Inflammation; Myocarditis; Sarcoidosis

2023
Diagnosis of cardiac sarcoidosis in patients presenting with cardiac arrest or life-threatening arrhythmias.
    Heart (British Cardiac Society), 2023, 04-25, Volume: 109, Issue:10

    Topics: Arrhythmias, Cardiac; Cardiomyopathies; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium; Heart Arrest; Humans; Inflammation; Magnetic Resonance Imaging; Male; Middle Aged; Myocarditis; Sarcoidosis

2023
Prednisone vs methotrexate in treatment naïve cardiac sarcoidosis.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2023, Volume: 30, Issue:4

    Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Methotrexate; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Stroke Volume; Ventricular Function, Left

2023
The Mechanism and Natural History of Mitral Regurgitation in Cardiac Sarcoidosis.
    The American journal of cardiology, 2023, 03-15, Volume: 191

    Topics: Fluorodeoxyglucose F18; Humans; Mitral Valve Insufficiency; Myocarditis; Sarcoidosis; Severity of Illness Index; Stroke Volume; Ventricular Function, Left

2023
Diagnostic yield of whole-body
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2023, Volume: 30, Issue:5

    Topics: Adult; Fluorodeoxyglucose F18; Humans; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis

2023
Optimal Timing of Serial
    International heart journal, 2023, Mar-31, Volume: 64, Issue:2

    Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Myocarditis; Positron-Emission Tomography; Prednisolone; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis

2023
What is this image? 2023 Image 6 result:
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2023, Volume: 30, Issue:3

    Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Myocarditis; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis

2023
Sex differences in cardiac sarcoidosis.
    Heart (British Cardiac Society), 2023, 08-24, Volume: 109, Issue:18

    Topics: Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Male; Myocarditis; Positron-Emission Tomography; Sarcoidosis; Sex Characteristics; Tachycardia, Ventricular

2023
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2023, Volume: 30, Issue:6

    Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis

2023
FDG-PET/CT and rest myocardial perfusion imaging to predict high-degree atrioventricular block recovery in cardiac sarcoidosis.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2023, Volume: 30, Issue:6

    Topics: Atrioventricular Block; Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Immunosuppressive Agents; Myocardial Perfusion Imaging; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis

2023
Displays of 18 F-FAPI PET/CT in Myocarditis With Variable Symptom Durations.
    Clinical nuclear medicine, 2023, Sep-01, Volume: 48, Issue:9

    Topics: Biological Transport; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Myocarditis; Positron Emission Tomography Computed Tomography

2023
Cardiac fludeoxyglucose-18 positron emission tomography in genotype-positive arrhythmogenic cardiomyopathy.
    International journal of cardiology, 2023, 10-15, Volume: 389

    Topics: Adult; Female; Fluorodeoxyglucose F18; Genotype; Humans; Inflammation; Male; Middle Aged; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals

2023
Can FDG PET/CT predict AV nodal recovery in cardiac sarcoidosis?
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2023, Volume: 30, Issue:6

    Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis

2023
An International Survey of Current Clinical Practice in the Treatment of Cardiac Sarcoidosis.
    The American journal of cardiology, 2023, 09-15, Volume: 203

    Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Myocarditis; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Sarcoidosis

2023
Complete resolution of focal-on-diffuse myocardial activity pattern on FDG PET-CT by prolonging the dietary preparation protocol in cardiac sarcoidosis.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2023, Volume: 30, Issue:6

    Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis

2023
Clinical Response to Tumor Necrosis Factor-α Inhibitor Therapy in the Management of Cardiac Sarcoidosis.
    The American journal of cardiology, 2023, 10-15, Volume: 205

    Topics: Adalimumab; Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Infliximab; Myocarditis; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Sarcoidosis; Tumor Necrosis Factor-alpha

2023
Detection of Active Inflammation Status Around Ventricular Aneurysms in Patients With Cardiac Sarcoidosis.
    Circulation journal : official journal of the Japanese Circulation Society, 2019, 11-25, Volume: 83, Issue:12

    Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Heart Aneurysm; Humans; Male; Middle Aged; Myocarditis; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sarcoidosis; Treatment Outcome

2019
Myocarditis Causing Premature Ventricular Contractions: Insights From the MAVERIC Registry.
    Circulation. Arrhythmia and electrophysiology, 2019, Volume: 12, Issue:12

    Topics: Adult; Aged; Biopsy; Catheter Ablation; Female; Fluorodeoxyglucose F18; Heart Rate; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Middle Aged; Myocarditis; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Recovery of Function; Registries; Risk Factors; Stroke Volume; Time Factors; Treatment Outcome; United States; Ventricular Function, Left; Ventricular Premature Complexes

2019
Serial
    Circulation. Cardiovascular imaging, 2020, Volume: 13, Issue:2

    Topics: Biopsy; Female; Fluorodeoxyglucose F18; Giant Cells; Humans; Middle Aged; Myocarditis; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals

2020
Hybrid FDG-PET/MR or FDG-PET/CT to Detect Disease Activity in Patients With Persisting Arrhythmias After Myocarditis.
    JACC. Cardiovascular imaging, 2021, Volume: 14, Issue:1

    Topics: Arrhythmias, Cardiac; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals

2021
Concurrent native valve infective endocarditis and myocarditis: the key role of
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2021, Volume: 28, Issue:4

    Topics: Echocardiography; Endocarditis; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocarditis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals

2021
Quantitative Assessment of Cardiac Hypermetabolism and Perfusion for Diagnosis of Cardiac Sarcoidosis.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2022, Volume: 29, Issue:1

    Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Myocarditis; Perfusion; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed

2022
Regarding "Waxing and Waning Presentation of Isolated Cardiac Sarcoidosis on Sequential
    Journal of nuclear medicine technology, 2021, Volume: 49, Issue:3

    Topics: Fluorodeoxyglucose F18; Humans; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis

2021
Diagnostic utility of fusion
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2022, Volume: 29, Issue:2

    Topics: Cardiomyopathies; Contrast Media; Fluorodeoxyglucose F18; Gadolinium; Humans; Magnetic Resonance Imaging; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis

2022
A Patient Presenting With a Viral Prodrome, Palpitations, Dizziness, and Heart Block.
    JAMA cardiology, 2021, 02-01, Volume: 6, Issue:2

    Topics: Blood Sedimentation; C-Reactive Protein; Cardiac Pacing, Artificial; Cardiac Resynchronization Therapy; Dizziness; Electrocardiography; Fluorodeoxyglucose F18; Glucocorticoids; Heart Block; Humans; Myocarditis; Pacemaker, Artificial; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Virus Diseases; Young Adult

2021
Pre-Treatment Myocardial
    JACC. Cardiovascular imaging, 2021, Volume: 14, Issue:10

    Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Immunosuppression Therapy; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sarcoidosis; Stroke Volume; Ventricular Function, Left

2021
Positron emission tomography in clinically suspected myocarditis - STREAM study design.
    International journal of cardiology, 2021, 06-01, Volume: 332

    Topics: Aftercare; Cohort Studies; Fluorodeoxyglucose F18; Humans; Myocarditis; Patient Discharge; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity

2021
A Case of Rapidly Progressing Granulomatous Myocarditis: What Is the Diagnosis?
    Circulation. Heart failure, 2021, Volume: 14, Issue:3

    Topics: Atrioventricular Block; Biopsy; Cardiomyopathies; Diagnosis, Differential; Disease Progression; Echocardiography; Fluorodeoxyglucose F18; Giant Cells; Granuloma; Heart Block; Heart Failure; Heart Transplantation; Humans; Lymph Nodes; Magnetic Resonance Imaging; Male; Middle Aged; Myocarditis; Myocardium; Natriuretic Peptide, Brain; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis; Stroke Volume; Troponin I

2021
Arrhythmogenic cardiomyopathy presenting as an inflammatory cardiomyopathy: the role of 18F-fluorodeoxyglucose positron emission tomography scan.
    European heart journal. Cardiovascular Imaging, 2021, 07-20, Volume: 22, Issue:8

    Topics: Fluorodeoxyglucose F18; Humans; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals

2021
Localization of myocardial FDG uptake for prognostic risk stratification in corticosteroid-naïve cardiac sarcoidosis.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2022, Volume: 29, Issue:5

    Topics: Adrenal Cortex Hormones; Aged; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocarditis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Risk Assessment; Sarcoidosis; Tachycardia, Ventricular; Tomography, X-Ray Computed

2022
Initial Experience With Simultaneous 18F-FDG PET/MRI in the Evaluation of Cardiac Sarcoidosis and Myocarditis.
    Clinical nuclear medicine, 2017, Volume: 42, Issue:7

    Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Myocarditis; Positron-Emission Tomography; Sarcoidosis

2017
Myocarditis with high
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2018, Volume: 25, Issue:2

    Topics: Dideoxynucleosides; Electrocardiography; Fluorodeoxyglucose F18; Heart; Humans; Inflammation; Male; Myocarditis; Myocardium; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Young Adult

2018
Prognostic value of fluorine-18 fluoro-2-deoxyglucose positron emission computed tomography in patients with unexplained atrioventricular block.
    Heart rhythm, 2018, Volume: 15, Issue:2

    Topics: Adolescent; Adult; Atrioventricular Block; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocarditis; Myocardium; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Young Adult

2018
Longitudinal 18F-FDG PET imaging in a rat model of autoimmune myocarditis.
    European heart journal. Cardiovascular Imaging, 2019, 04-01, Volume: 20, Issue:4

    Topics: Acute Disease; Animals; Autoimmune Diseases; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Inflammation; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Inbred Lew

2019
A 1-week extension of a ketogenic diet provides a further decrease in myocardial
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2020, Volume: 27, Issue:2

    Topics: Animal Feed; Animals; Diet, Carbohydrate-Restricted; Diet, Ketogenic; Dietary Carbohydrates; Fasting; Fluorodeoxyglucose F18; Heart; Heart Diseases; Inflammation; Male; Myocarditis; Myocardium; Myosins; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Wistar; Swine

2020
Stop that glucose getting to heart!
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2020, Volume: 27, Issue:2

    Topics: Animals; Diet, Ketogenic; Fluorodeoxyglucose F18; Glucose; Humans; Mice; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis

2020
Myocardial Inflammation, Measured Using 18-Fluorodeoxyglucose Positron Emission Tomography With Computed Tomography, Is Associated With Disease Activity in Rheumatoid Arthritis.
    Arthritis & rheumatology (Hoboken, N.J.), 2019, Volume: 71, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Fluorodeoxyglucose F18; Heart; Humans; Linear Models; Longitudinal Studies; Male; Middle Aged; Multivariate Analysis; Myocarditis; Myocardium; Pilot Projects; Positron Emission Tomography Computed Tomography; Prevalence; Radiopharmaceuticals; Risk Factors; Severity of Illness Index; Young Adult

2019
Prevalence of
    International journal of cardiology, 2019, 06-01, Volume: 284

    Topics: Adult; Arrhythmogenic Right Ventricular Dysplasia; Biopsy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocarditis; Myocardium; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Survival Rate; United Kingdom

2019
Assessing severity of cardiac sarcoid: Is SUV the answer?
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2020, Volume: 27, Issue:6

    Topics: Fluorodeoxyglucose F18; Heart; Humans; Myocarditis; Prognosis; Sarcoidosis

2020
Feasibility of somatostatin receptor-targeted imaging for detection of myocardial inflammation: A pilot study.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2021, Volume: 28, Issue:3

    Topics: Aged; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocarditis; Organometallic Compounds; Pilot Projects; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Receptors, Somatostatin; Sarcoidosis; Sensitivity and Specificity

2021
Somatostatin receptor imaging in active cardiac sarcoidosis: Would less be enough?
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2021, Volume: 28, Issue:3

    Topics: Fluorodeoxyglucose F18; Humans; Myocarditis; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Receptors, Somatostatin; Sarcoidosis; Sensitivity and Specificity

2021
Significant suppression of myocardial (18)F-fluorodeoxyglucose uptake using 24-h carbohydrate restriction and a low-carbohydrate, high-fat diet.
    Journal of cardiology, 2013, Volume: 62, Issue:5

    Topics: Adult; Aged; Diet, Carbohydrate-Restricted; Dietary Carbohydrates; Dietary Fats; Female; Fluorodeoxyglucose F18; Heart; Heart Ventricles; Humans; Male; Middle Aged; Myocarditis; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; Time Factors

2013
Determination of optimum periods between onset of suspected acute myocarditis and ¹⁸F-fluorodeoxyglucose positron emission tomography in the diagnosis of inflammatory left ventricular myocardium.
    International journal of cardiology, 2013, Nov-05, Volume: 169, Issue:3

    Topics: Acute Disease; Adult; Aged; Female; Fluorodeoxyglucose F18; Heart Ventricles; Humans; Inflammation; Male; Middle Aged; Myocarditis; Positron-Emission Tomography; Retrospective Studies; Time Factors

2013
Multiparametric assessment of myocarditis using simultaneous positron emission tomography/magnetic resonance imaging.
    European heart journal, 2014, Aug-21, Volume: 35, Issue:32

    Topics: Adult; Edema, Cardiac; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Angiography; Male; Multimodal Imaging; Myocarditis; Parvoviridae Infections; Parvovirus B19, Human; Positron-Emission Tomography; Radiopharmaceuticals

2014
Detection of acute inflammatory myocarditis in Epstein Barr virus infection using hybrid 18F-fluoro-deoxyglucose-positron emission tomography/magnetic resonance imaging.
    Circulation, 2014, Sep-09, Volume: 130, Issue:11

    Topics: Acute Disease; Cardiac Imaging Techniques; Epstein-Barr Virus Infections; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Young Adult

2014
Utility of cardiac FDG-PET imaging coupled to magnetic resonance for the management of an acute myocarditis with non-informative endomyocardial biopsy.
    European heart journal. Cardiovascular Imaging, 2015, Volume: 16, Issue:5

    Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Biopsy; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals

2015
The role of 18F fluorodeoxyglucose positron emission tomography (18F-FDG-PET) in children with rheumatic carditis and chronic rheumatic heart disease.
    Nuclear medicine review. Central & Eastern Europe, 2015, Volume: 18, Issue:1

    Topics: Adolescent; Child; Chronic Disease; Female; Fluorodeoxyglucose F18; Humans; Male; Myocarditis; Positron-Emission Tomography; Rheumatic Heart Disease

2015
Infectious Myocarditis on FDG-PET Imaging Mimicking Sarcoidosis.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2015, Volume: 22, Issue:4

    Topics: Diagnosis, Differential; Diagnostic Errors; Fluorodeoxyglucose F18; Humans; Male; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tuberculosis, Cardiovascular; Young Adult

2015
Imaging of myocardial inflammation with somatostatin receptor based PET/CT - A comparison to cardiac MRI.
    International journal of cardiology, 2015, Sep-01, Volume: 194

    Topics: Adult; Aged; Electrocardiography; Female; Fluorodeoxyglucose F18; Humans; Macrophages; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Myocardial Infarction; Myocarditis; Octreotide; Organometallic Compounds; Positron-Emission Tomography; Prospective Studies; Radiography; Radiopharmaceuticals; Receptors, Somatostatin

2015
Incidence of abnormal positron emission tomography in patients with unexplained cardiomyopathy and ventricular arrhythmias: The potential role of occult inflammation in arrhythmogenesis.
    Heart rhythm, 2015, Volume: 12, Issue:12

    Topics: Adult; Aged; Arrhythmias, Cardiac; Cardiomyopathies; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Incidence; Inflammation; Lymph Nodes; Male; Middle Aged; Multimodal Imaging; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Referral and Consultation; Tomography, X-Ray Computed

2015
The Evaluation of Lupus Myocarditis with 13N-Ammonia and 18F-FDG PET.
    Journal of nuclear medicine technology, 2016, Volume: 44, Issue:3

    Topics: Ammonia; Female; Fluorodeoxyglucose F18; Humans; Lupus Erythematosus, Systemic; Myocarditis; Nitrogen Radioisotopes; Positron-Emission Tomography; Young Adult

2016
F-18 sodium fluoride PET/CT does not effectively image myocardial inflammation due to suspected cardiac sarcoidosis.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2017, Volume: 24, Issue:6

    Topics: Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocarditis; Pilot Projects; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis; Sodium Fluoride

2017
Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2017, Volume: 24, Issue:1

    Topics: Cardiac Imaging Techniques; Diet, Carbohydrate-Restricted; Fasting; Fluorodeoxyglucose F18; Humans; Image Enhancement; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity

2017
Clinical Utility of Combined FDG-PET/MR to Assess Myocardial Disease.
    JACC. Cardiovascular imaging, 2017, Volume: 10, Issue:5

    Topics: Adult; Female; Fluorodeoxyglucose F18; Heart Failure; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Myocardial Infarction; Myocarditis; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Sarcoidosis

2017
Feasibility of FDG-PET in myocarditis: Comparison to CMR using integrated PET/MRI.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2018, Volume: 25, Issue:3

    Topics: Adult; Contrast Media; Feasibility Studies; Female; Fluorodeoxyglucose F18; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Myocarditis; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals

2018
Cardiac PET/MRI enters the clinical arena! Finally….
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2018, Volume: 25, Issue:3

    Topics: Feasibility Studies; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Myocarditis; Positron-Emission Tomography

2018
Role of 18F-Fluorodeoxyglucose/Positron Emission Tomography Imaging to Demonstrate Resolution of Acute Myocarditis.
    The Canadian journal of cardiology, 2017, Volume: 33, Issue:2

    Topics: Acute Disease; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Remission, Spontaneous; Time Factors; Young Adult

2017
Myocardial Blood Flow and Inflammatory Cardiac Sarcoidosis.
    JACC. Cardiovascular imaging, 2017, Volume: 10, Issue:2

    Topics: Ammonia; Blood Flow Velocity; Cardiomyopathies; Coronary Circulation; Female; Fluorodeoxyglucose F18; Humans; Hyperemia; Immunosuppressive Agents; Male; Middle Aged; Myocardial Perfusion Imaging; Myocarditis; Nitrogen Radioisotopes; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Time Factors; Treatment Outcome; Vasodilation

2017
PET/MRI of inflammation in myocardial infarction.
    Journal of the American College of Cardiology, 2012, Jan-10, Volume: 59, Issue:2

    Topics: Aged; Animals; Case-Control Studies; Female; Fluorodeoxyglucose F18; Humans; Macrophages; Magnetic Resonance Imaging; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Middle Aged; Monocytes; Myocardial Infarction; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals

2012
Usefulness of fluorine-18 positron emission tomography/computed tomography for identification of cardiovascular implantable electronic device infections.
    Journal of the American College of Cardiology, 2012, May-01, Volume: 59, Issue:18

    Topics: Aged; Arrhythmias, Cardiac; Cardiovascular Infections; Defibrillators, Implantable; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Morbidity; Multimodal Imaging; Myocarditis; Positron-Emission Tomography; Prospective Studies; Prosthesis-Related Infections; Quebec; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed

2012
Imaging for infected cardiac implantable electronic devices: a new trick for your pet.
    Journal of the American College of Cardiology, 2012, May-01, Volume: 59, Issue:18

    Topics: Cardiovascular Infections; Defibrillators, Implantable; Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Myocarditis; Positron-Emission Tomography; Prosthesis-Related Infections; Tomography, X-Ray Computed

2012
Churg-Strauss syndrome cardiac involvement evaluated by cardiac magnetic resonance imaging and positron-emission tomography: a prospective study on 20 patients.
    Rheumatology (Oxford, England), 2013, Volume: 52, Issue:4

    Topics: Adult; Churg-Strauss Syndrome; Diagnosis, Differential; Female; Fibrosis; Fluorodeoxyglucose F18; Heart Diseases; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocarditis; Myocardium; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Remission Induction

2013
Clinical utility of 18F-FDG positron emission tomography and computed tomography in patients with suspected cardiovascular implantable electronic device infection.
    Journal of the American College of Cardiology, 2012, Oct-09, Volume: 60, Issue:15

    Topics: Cardiovascular Infections; Defibrillators, Implantable; Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Myocarditis; Positron-Emission Tomography; Prosthesis-Related Infections; Tomography, X-Ray Computed

2012
The use of 18F-FDG-PET/CT in the diagnostic workup of CIED infections: another perspective.
    Journal of the American College of Cardiology, 2012, Oct-09, Volume: 60, Issue:15

    Topics: Cardiovascular Infections; Defibrillators, Implantable; Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Myocarditis; Positron-Emission Tomography; Prosthesis-Related Infections; Tomography, X-Ray Computed

2012
Absence of cardiovascular implantable electronic device infection in remote implantations demonstrated by fluorine-18 positron emission tomography.
    Journal of the American College of Cardiology, 2012, Nov-20, Volume: 60, Issue:21

    Topics: Cardiovascular Infections; Defibrillators, Implantable; Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Myocarditis; Positron-Emission Tomography; Prosthesis-Related Infections; Tomography, X-Ray Computed

2012
Clinical value of a high-fat and low-carbohydrate diet before FDG-PET/CT for evaluation of patients with suspected cardiac sarcoidosis.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2013, Volume: 20, Issue:1

    Topics: Aged; Diet, Carbohydrate-Restricted; Diet, High-Fat; Dietary Carbohydrates; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Monitoring, Ambulatory; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed

2013
Detection of pacemaker and lead infection with FDG-PET.
    European journal of nuclear medicine and molecular imaging, 2006, Volume: 33, Issue:10

    Topics: Adult; Electrodes, Implanted; Female; Fluorodeoxyglucose F18; Humans; Myocarditis; Pacemaker, Artificial; Positron-Emission Tomography; Prosthesis-Related Infections; Radiopharmaceuticals; Staphylococcal Infections

2006
Papillary muscle inflammation in Takayasu's arteritis revealed by FDG-PET.
    European heart journal, 2007, Volume: 28, Issue:8

    Topics: Adolescent; Crohn Disease; Female; Fluorodeoxyglucose F18; Humans; Myocarditis; Papillary Muscles; Positron-Emission Tomography; Radiopharmaceuticals; Takayasu Arteritis

2007
[18F] Fluorodeoxyglucose positron-emission tomography-CT imaging of carotidynia.
    AJNR. American journal of neuroradiology, 2008, Volume: 29, Issue:6

    Topics: Aged; Carotid Artery Diseases; Female; Fluorodeoxyglucose F18; Humans; Myocarditis; Neck Pain; Positron-Emission Tomography; Radiopharmaceuticals; Syndrome; Tomography, X-Ray Computed

2008